Analyst Price Target is $10.00
▲ +40.45% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Aurinia Pharmaceuticals in the last 3 months. The average price target is $10.00, with a high forecast of $13.00 and a low forecast of $8.00. The average price target represents a 40.45% upside from the last price of $7.12.
Current Consensus is
Moderate Buy
The current consensus among 4 polled investment analysts is to moderate buy stock in Aurinia Pharmaceuticals. This rating has held steady since February 2024, when it changed from a Buy consensus rating.